The latest study on Nucleic Acid-based Therapeutics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Nucleic Acid-based Therapeutics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Nucleic Acid-based Therapeutics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
Nucleic Acid-based Therapeutics Market Analysis By Type Segment:
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Nucleic Acid-based Therapeutics Market Analysis By Application Segment:
Monogenetic Disorders
Multi-Genetic Disorders
Nucleic Acid-based Therapeutics Market Analysis By Regions (Countries):
The Nucleic Acid-based Therapeutics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Nucleic Acid-based Therapeutics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Nucleic Acid-based Therapeutics Market:
Nucleic Acid-based Therapeutics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Nucleic Acid-based Therapeutics Market status and future forecast.
To present the key Nucleic Acid-based Therapeutics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (2016-2027)
1.4.2 Anti-Sense And Anti-Gene
1.4.3 Short Inhibitory Sequences
1.4.4 Gene Transfer Therapy
1.4.5 Nucleoside Analogs
1.4.6 Ribozymes
1.4.7 Aptamers
1.5 Market by Application
1.5.1 Global Nucleic Acid-based Therapeutics Market Share by Application (2016-2027)
1.5.2 Monogenetic Disorders
1.5.3 Multi-Genetic Disorders
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Nucleic Acid-based Therapeutics Market Size
2.2 Nucleic Acid-based Therapeutics Growth Trends by Regions
2.2.1 Nucleic Acid-based Therapeutics Market Size by Regions (2016-2027)
2.2.2 Nucleic Acid-based Therapeutics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Nucleic Acid-based Therapeutics Market Size by Manufacturers
3.1.1 Global Nucleic Acid-based Therapeutics Revenue by Manufacturers (2020)
3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Manufacturers (2020)
3.1.3 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Nucleic Acid-based Therapeutics Key Players Head office and Area Served
3.3 Key Players Nucleic Acid-based Therapeutics Product/Solution/Service
3.4 Date of Enter into Nucleic Acid-based Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Nucleic Acid-based Therapeutics Market Size by Type (2016-2020)
4.2 Global Nucleic Acid-based Therapeutics Market Size by Application (2016-2020)
5 United States
5.1 United States Nucleic Acid-based Therapeutics Market Size (2016-2020)
5.2 Nucleic Acid-based Therapeutics Key Players in United States
5.3 United States Nucleic Acid-based Therapeutics Market Size by Type
5.4 United States Nucleic Acid-based Therapeutics Market Size by Application
6 Europe
6.1 Europe Nucleic Acid-based Therapeutics Market Size (2016-2020)
6.2 Nucleic Acid-based Therapeutics Key Players in Europe
6.3 Europe Nucleic Acid-based Therapeutics Market Size by Type
6.4 Europe Nucleic Acid-based Therapeutics Market Size by Application
7 China
7.1 China Nucleic Acid-based Therapeutics Market Size (2016-2020)
7.2 Nucleic Acid-based Therapeutics Key Players in China
7.3 China Nucleic Acid-based Therapeutics Market Size by Type
7.4 China Nucleic Acid-based Therapeutics Market Size by Application
8 Japan
8.1 Japan Nucleic Acid-based Therapeutics Market Size (2016-2020)
8.2 Nucleic Acid-based Therapeutics Key Players in Japan
8.3 Japan Nucleic Acid-based Therapeutics Market Size by Type
8.4 Japan Nucleic Acid-based Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Nucleic Acid-based Therapeutics Market Size (2016-2020)
9.2 Nucleic Acid-based Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type
9.4 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application
10 India
10.1 India Nucleic Acid-based Therapeutics Market Size (2016-2020)
10.2 Nucleic Acid-based Therapeutics Key Players in India
10.3 India Nucleic Acid-based Therapeutics Market Size by Type
10.4 India Nucleic Acid-based Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Nucleic Acid-based Therapeutics Market Size (2016-2020)
11.2 Nucleic Acid-based Therapeutics Key Players in Central & South America
11.3 Central & South America Nucleic Acid-based Therapeutics Market Size by Type
11.4 Central & South America Nucleic Acid-based Therapeutics Market Size by Application
12 International Players Profiles
12.1 Wave Life Sciences
12.1.1 Wave Life Sciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nucleic Acid-based Therapeutics Introduction
12.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.1.5 Wave Life Sciences Recent Development
12.2 Imugene
12.2.1 Imugene Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nucleic Acid-based Therapeutics Introduction
12.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.2.5 Imugene Recent Development
12.3 Caperna
12.3.1 Caperna Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nucleic Acid-based Therapeutics Introduction
12.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.3.5 Caperna Recent Development
12.4 Phylogica
12.4.1 Phylogica Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nucleic Acid-based Therapeutics Introduction
12.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.4.5 Phylogica Recent Development
12.5 Protagonist Therapeutics
12.5.1 Protagonist Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nucleic Acid-based Therapeutics Introduction
12.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.5.5 Protagonist Therapeutics Recent Development
12.6 Benitec Biopharma
12.6.1 Benitec Biopharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nucleic Acid-based Therapeutics Introduction
12.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.6.5 Benitec Biopharma Recent Development
12.7 EGEN
12.7.1 EGEN Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nucleic Acid-based Therapeutics Introduction
12.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.7.5 EGEN Recent Development
12.8 BioMedica
12.8.1 BioMedica Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nucleic Acid-based Therapeutics Introduction
12.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.8.5 BioMedica Recent Development
12.9 Transgene
12.9.1 Transgene Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nucleic Acid-based Therapeutics Introduction
12.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.9.5 Transgene Recent Development
12.10 Copernicus Therapeutics
12.10.1 Copernicus Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nucleic Acid-based Therapeutics Introduction
12.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2020)
12.10.5 Copernicus Therapeutics Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Nucleic Acid-based Therapeutics Key Market Segments
Table Key Players Nucleic Acid-based Therapeutics Covered
Table Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type 2016-2027
Figure Anti-Sense And Anti-Gene Figures
Table Key Players of Anti-Sense And Anti-Gene
Figure Short Inhibitory Sequences Figures
Table Key Players of Short Inhibitory Sequences
Figure Gene Transfer Therapy Figures
Table Key Players of Gene Transfer Therapy
Figure Nucleoside Analogs Figures
Table Key Players of Nucleoside Analogs
Figure Ribozymes Figures
Table Key Players of Ribozymes
Figure Aptamers Figures
Table Key Players of Aptamers
Table Global Nucleic Acid-based Therapeutics Market Size Growth by Application 2016-2027 (Million US$)
Figure Monogenetic Disorders Case Studies
Figure Multi-Genetic Disorders Case Studies
Figure Nucleic Acid-based Therapeutics Report Years Considered
Table Global Nucleic Acid-based Therapeutics Market Size 2016-2027 (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2016-2027 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2016-2020 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Share by Regions 2016-2020
Figure Global Nucleic Acid-based Therapeutics Market Share by Regions 2016-2020
Figure Global Nucleic Acid-based Therapeutics Market Share by Regions 2020
Table Market Top Trends
Table Global Nucleic Acid-based Therapeutics Revenue by Manufacturers (2020) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Share by Manufacturers (2020)
Figure Global Nucleic Acid-based Therapeutics Market Share by Manufacturers in 2020
Table Global Nucleic Acid-based Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nucleic Acid-based Therapeutics Product/Solution/Service
Table Date of Enter into Nucleic Acid-based Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nucleic Acid-based Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size Share by Type (2016-2020)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2016-2020)
Table Global Nucleic Acid-based Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size Share by Application (2016-2020)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2016-2020)
Figure Global Nucleic Acid-based Therapeutics Revenue Market Share by Application in 2020
Figure United States Nucleic Acid-based Therapeutics Market Size 2016-2020 (Million US$)
Table United States Key Players Nucleic Acid-based Therapeutics Revenue (2020) (Million US$)
Table United States Key Players Nucleic Acid-based Therapeutics Market Share (2020)
Table United States Nucleic Acid-based Therapeutics Market Size by Type (2016-2020) (Million US$)
Table United States Nucleic Acid-based Therapeutics Market Share by Type (2016-2020)
Table United States Nucleic Acid-based Therapeutics Market Size by Application (2016-2020) (Million US$)
Table United States Nucleic Acid-based Therapeutics Market Share by Application (2016-2020)
Figure Europe Nucleic Acid-based Therapeutics Market Size 2016-2020 (Million US$)
Table Europe Key Players Nucleic Acid-based Therapeutics Revenue (2020) (Million US$)
Table Europe Key Players Nucleic Acid-based Therapeutics Market Share (2020)
Table Europe Nucleic Acid-based Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Europe Nucleic Acid-based Therapeutics Market Share by Type (2016-2020)
Table Europe Nucleic Acid-based Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Europe Nucleic Acid-based Therapeutics Market Share by Application (2016-2020)
Figure China Nucleic Acid-based Therapeutics Market Size 2016-2020 (Million US$)
Table China Key Players Nucleic Acid-based Therapeutics Revenue (2020) (Million US$)
Table China Key Players Nucleic Acid-based Therapeutics Market Share (2020)
Table China Nucleic Acid-based Therapeutics Market Size by Type (2016-2020) (Million US$)
Table China Nucleic Acid-based Therapeutics Market Share by Type (2016-2020)
Table China Nucleic Acid-based Therapeutics Market Size by Application (2016-2020) (Million US$)
Table China Nucleic Acid-based Therapeutics Market Share by Application (2016-2020)
Figure Japan Nucleic Acid-based Therapeutics Market Size 2016-2020 (Million US$)
Table Japan Key Players Nucleic Acid-based Therapeutics Revenue (2020) (Million US$)
Table Japan Key Players Nucleic Acid-based Therapeutics Market Share (2020)
Table Japan Nucleic Acid-based Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Japan Nucleic Acid-based Therapeutics Market Share by Type (2016-2020)
Table Japan Nucleic Acid-based Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Japan Nucleic Acid-based Therapeutics Market Share by Application (2016-2020)
Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Nucleic Acid-based Therapeutics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Nucleic Acid-based Therapeutics Market Share (2020)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Share by Type (2016-2020)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Share by Application (2016-2020)
Figure India Nucleic Acid-based Therapeutics Market Size 2016-2020 (Million US$)
Table India Key Players Nucleic Acid-based Therapeutics Revenue (2020) (Million US$)
Table India Key Players Nucleic Acid-based Therapeutics Market Share (2020)
Table India Nucleic Acid-based Therapeutics Market Size by Type (2016-2020) (Million US$)
Table India Nucleic Acid-based Therapeutics Market Share by Type (2016-2020)
Table India Nucleic Acid-based Therapeutics Market Size by Application (2016-2020) (Million US$)
Table India Nucleic Acid-based Therapeutics Market Share by Application (2016-2020)
Figure Central & South America Nucleic Acid-based Therapeutics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Nucleic Acid-based Therapeutics Revenue (2020) (Million US$)
Table Central & South America Key Players Nucleic Acid-based Therapeutics Market Share (2020)
Table Central & South America Nucleic Acid-based Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Nucleic Acid-based Therapeutics Market Share by Type (2016-2020)
Table Central & South America Nucleic Acid-based Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Nucleic Acid-based Therapeutics Market Share by Application (2016-2020)
Table Wave Life Sciences Company Details
Table Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2020) (Million US$)
Figure Wave Life Sciences Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table Wave Life Sciences Recent Development
Table Imugene Company Details
Table Imugene Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure Imugene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table Imugene Recent Development
Table Caperna Company Details
Table Caperna Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure Caperna Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table Caperna Recent Development
Table Phylogica Company Details
Table Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure Phylogica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table Phylogica Recent Development
Table Protagonist Therapeutics Company Details
Table Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure Protagonist Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table Protagonist Therapeutics Recent Development
Table Benitec Biopharma Company Details
Table Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure Benitec Biopharma Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table Benitec Biopharma Recent Development
Table EGEN Company Details
Table EGEN Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure EGEN Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table EGEN Recent Development
Table BioMedica Company Details
Table BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure BioMedica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table BioMedica Recent Development
Table Transgene Company Details
Table Transgene Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure Transgene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table Transgene Recent Development
Table Copernicus Therapeutics Company Details
Table Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2020)(Million US$)
Figure Copernicus Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020)
Table Copernicus Therapeutics Recent Development
Table Global Nucleic Acid-based Therapeutics Market Size by Regions (Million US$) 2021-2027
Figure Global Nucleic Acid-based Therapeutics Market Size Share by Regions (2021-2027)
Figure Global Nucleic Acid-based Therapeutics Market Size Share by Regions in 2027
Figure United States Nucleic Acid-based Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Nucleic Acid-based Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure China Nucleic Acid-based Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Nucleic Acid-based Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure India Nucleic Acid-based Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Nucleic Acid-based Therapeutics Market Size Forecast (2021-2027)(Million USD)
Table Global Nucleic Acid-based Therapeutics Market Size by Product (2021-2027) (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size by Product (2021-2027)
Figure Global Nucleic Acid-based Therapeutics Market Size by Product in 2027
Table Global Nucleic Acid-based Therapeutics Market Size by Application (2021-2027) (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size by Application (2021-2027)
Figure Global Nucleic Acid-based Therapeutics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources